title: Structure-activity relationships for perfluoroalkane-induced in vitro interference with rat liver mitochondrial respiration.
abstract: Perfluorinated alkyl acids (PFAAs) represent a broad class of commercial products designed primarily for the coatings industry. However, detection of residues globally in a variety of species led to the discontinuation of production in the U.S. Although PFAAs cause activation of the PPARα and CAR nuclear receptors, interference with mitochondrial bioenergetics has been implicated as an alternative mechanism of cytotoxicity. Although the mechanisms by which the eight carbon chain PFAAs interfere with mitochondrial bioenergetics are fairly well described, the activities of the more highly substituted or shorter chain PFAAs are far less well characterized. The current investigation was designed to explore structure-activity relationships by which PFAAs interfere with mitochondrial respiration in vitro. Freshly isolated rat liver mitochondria were incubated with one of 16 different PFAAs, including perfluorinated carboxylic, acetic, and sulfonic acids, sulfonamides and sulfamido acetates, and alcohols. The effect on mitochondrial respiration was measured at five concentrations and dose-response curves were generated to describe the effects on state 3 and 4 respiration and respiratory control. With the exception of PFOS, all PFAAs at sufficiently high concentrations (>20μM) stimulated state 4 and inhibited state 3 respiration. Stimulation of state 4 respiration was most pronounced for the carboxylic acids and the sulfonamides, which supports prior evidence that the perfluorinated carboxylic and acetic acids induce the mitochondrial permeability transition, whereas the sulfonamides are protonophoric uncouplers of oxidative phosphorylation. In both cases, potency increased with increasing carbon number, with a prominent inflection point between the six and eight carbon congeners. The results provide a foundation for classifying PFAAs according to specific modes of mitochondrial activity and, in combination with toxicokinetic considerations, establishing structure-activity-based boundaries for initial estimates of risk for noncancer endpoints for PFAAs for which minimal in vivo toxicity testing currently exists.
authors: University of Minnesota Medical School, Department of Biochemistry and Molecular Biology, Duluth, MN 55812, United States. Electronic address: kwallace@d.umn.edu.
authors: K B
authors: KB
authors: Wallace
authors: G E
authors: GE
authors: Kissling
authors: R L
authors: RL
authors: Melnick
authors: C R
authors: CR
authors: Blystone
mesh_terms: D000473:Alkanes / Q000633:toxicity*; D000476:Alkanesulfonates / Q000633:toxicity; D000818:Animals; D019069:Cell Respiration / Q000187:drug effects*; D005466:Fluorocarbons / Q000633:toxicity*; D066298:In Vitro Techniques; D008297:Male; D008930:Mitochondria, Liver / Q000187:drug effects* / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013329:Structure-Activity Relationship
chemical_list: D000473:Alkanes; D000476:Alkanesulfonates; D005466:Fluorocarbons
keywords: Mitochondria; Perfluoroalkyl acids (PFAA); Structure–activity
references: Environ Sci Technol. 2011 Oct 1;45(19):7954-61
references: 21866930
references: Toxicol Sci. 2009 Sep;111(1):89-99
references: 19407336
references: Biochim Biophys Acta. 1990 Apr 26;1016(3):344-8
references: 2331477
references: Toxicol Appl Pharmacol. 2009 Mar 1;235(2):182-90
references: 19135466
references: Environ Health Perspect. 2007 Nov;115(11):1596-602
references: 18007991
references: Toxicol In Vitro. 2007 Sep;21(6):1206-11
references: 17572060
references: Toxicol Appl Pharmacol. 2011 Mar 1;251(2):163-8
references: 21236286
references: Toxicol Pathol. 2008 Jun;36(4):592-607
references: 18467677
references: Toxicol Sci. 2007 Oct;99(2):366-94
references: 17519394
references: Chem Res Toxicol. 2006 Oct;19(10):1305-12
references: 17040099
references: Anal Biochem. 1976 May 7;72:248-54
references: 942051
references: Toxicol Sci. 2007 Jan;95(1):108-17
references: 17047030
references: Toxicol Sci. 1999 Mar;48(1):82-9
references: 10330687
references: Toxicol Appl Pharmacol. 1999 Dec 1;161(2):209-18
references: 10581215
references: Environ Sci Technol. 2011 Oct 1;45(19):8022-9
references: 21528903
references: Toxicol Sci. 2008 May;103(1):46-56
references: 18281256
references: Toxicol In Vitro. 1990;4(1):71-4
references: 20702287
references: Environ Health Perspect. 2006 Nov;114(11):1776-82
references: 17107867
references: Toxicol Sci. 2002 Apr;66(2):244-52
references: 11896291
references: Toxicol Sci. 2006 Aug;92(2):476-89
references: 16731579
references: Toxicol Sci. 2008 Nov;106(1):162-71
references: 18713766
references: J Toxicol Environ Health. 1990;29(3):329-36
references: 2313742
references: Toxicol Sci. 2004 Nov;82(1):333-40
references: 15310855
references: Environ Sci Technol. 2001 Apr 1;35(7):1339-42
references: 11348064